Page last updated: 2024-11-11

kedarcidin chromophore

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

kedarcidin chromophore: a 9-membered enediyne, isolated from an actinomycete strain; embedded in kedarcidin peptide; extremely active against P388 leukemia & B16 melanoma; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6444256
MeSH IDM0215182

Synonyms (4)

Synonym
kedarcidin chromophore
143591-04-2
2-naphthalenecarboxamide, n-(13-chloro-2,3,6,7-tetradehydro-10-((2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)oxy)-1a,9-dihydro-20-oxo-23-((2,4,6-trideoxy-4-(dimethylamino)-alpha-l-lyxo-hexopyranosyl)oxy)-9,5-(epoxy(5,2)pyridinopropanoxyethano)-10h-c
n-[(3s,9r,14s,15e,19s,21r,24r)-6-chloro-24-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-14-[(2s,4s,5s,6s)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy-11-oxo-4,12,20-trioxa-7-azapentacyclo[13.6.2.25,8.13,21.019,21]hexacosa-1,5,7,15,25-penta

Research Excerpts

Overview

Kedarcidin chromophore is a 9-membered enediyne, recently isolated from an actinomycete strain.

ExcerptReferenceRelevance
"Kedarcidin chromophore is a 9-membered enediyne, recently isolated from an actinomycete strain. "( Kedarcidin chromophore: an enediyne that cleaves DNA in a sequence-specific manner.
Casazza, AM; Colson, KL; Doyle, TW; Leet, JE; Schroeder, DR; Solomon, W; Zein, N, 1993
)
3.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (42.11)18.2507
2000's9 (47.37)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.32 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]